Follow
Gagan Kaushal
Gagan Kaushal
Verified email at jefferson.edu
Title
Cited by
Cited by
Year
Expression of tryptophan 2, 3-dioxygenase in metastatic uveal melanoma
M Terai, E Londin, A Rochani, E Link, B Lam, G Kaushal, A Bhushan, ...
Cancers 12 (2), 405, 2020
312020
Normal flora: living vehicles for non-invasive protein drug delivery
J Shao, G Kaushal
International journal of pharmaceutics 286 (1-2), 117-124, 2004
242004
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase
N Sharma, A Bhushan, J He, G Kaushal, V Bhardwaj
Cancer & metabolism 8, 1-11, 2020
212020
Dental care–related fear and anxiety: distress tolerance as a possible mechanism
SH Addicks, DW McNeil, CL Randall, A Goddard, LM Romito, C Sirbu, ...
JDR Clinical & Translational Research 2 (3), 304-311, 2017
202017
Pharmacokinetics of ketamine at dissociative doses in an adult patient with refractory status asthmaticus receiving extracorporeal membrane oxygenation therapy
E Lam, A Rochani, G Kaushal, BN Thoma, J Tanjuakio, FM West, ...
Clinical therapeutics 41 (5), 994-999, 2019
142019
Initial characterization of D-cycloserine for future formulation development for anxiety disorders
G Kaushal, R Ramirez, D Alambo, W Taupradist, K Choksi, C Sirbu
Drug Discoveries & Therapeutics 5 (5), 253-260, 2011
142011
Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags
G Kaushal, BE Sayre, T Prettyman
Drug Discoveries & Therapeutics 6 (1), 49-54, 2012
132012
Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer
G Kaushal, L Trombetta, RS Ochs, J Shao
International journal of pharmaceutics 313 (1-2), 29-35, 2006
122006
Oral delivery of β-lactamase by Lactococcus lactis subsp. lactis transformed with Plasmid ss80
G Kaushal, J Shao
International journal of pharmaceutics 312 (1-2), 90-95, 2006
122006
Heat shock protein 90 (Hsp90)-inhibitor-luminespib-loaded-protein-based nanoformulation for cancer therapy
A K. Rochani, S Balasubramanian, A Ravindran Girija, T Maekawa, ...
Polymers 12 (8), 1798, 2020
92020
Simultaneous quantitative LC–MS method of ketamine, midazolam and their metabolites (dehydronorketamine, norketamine and 1hydroxymidazolam) for its application in patients on …
A Rochani, E Lam, J Tanjuakio, H Hirose, WK Kraft, G Kaushal
Journal of pharmaceutical and biomedical analysis 178, 112947, 2020
92020
Significance of stability-indicating LC methods in pharmaceuticals
G Goparaju, G Kaushal
Austin Chromatogr 1 (1), 2, 2014
92014
Randomized trial of prophylactic antibiotics vs. placebo after midshaft-to-distal hypospadias repair: The PROPHY Study
MA Faasse, WA Farhat, I Rosoklija, R Shannon, RI Odeh, GM Yoshiba, ...
Journal of pediatric urology 18 (2), 171-177, 2022
82022
Development and preclinical investigation of physically cross-linked and ph-sensitive polymeric gels as potential vaginal contraceptives
A Rochani, V Agrahari, N Chandra, ON Singh, TJ McCormick, GF Doncel, ...
Polymers 14 (9), 1728, 2022
72022
A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain
TJ Schnitzer, S Torbey, K Herrmann, G Kaushal, R Yeasted, ...
Molecular Pain 12, 1744806916678627, 2016
72016
Stability-indicating HPLC method for the determination of the stability of extemporaneously prepared norepinephrine parenteral solutions
G Kaushal, BE Sayre, T Prettyman
Journal of liquid chromatography & related technologies 35 (18), 2533-2544, 2012
62012
Tumoral oxygenation and biodistribution of Lonidamine oxygen microbubbles following localized ultrasound-triggered delivery
Q Lacerda, A Rochani, B Oeffinger, JB Liu, CE Wessner, A Tahmasebi, ...
International journal of pharmaceutics 625, 122072, 2022
52022
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
R Eudy‐Byrne, N Zane, SC Adeniyi‐Jones, MR Gastonguay, ...
Clinical and Translational Science 14 (6), 2171-2183, 2021
52021
LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions
AK Rochani, M Wheatley, BE Oeffinger, JR Eisenbrey, G Kaushal
Research in Pharmaceutical Sciences 15 (4), 312-322, 2020
52020
D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels
Y Shin, R Kokate, V Desai, A Bhushan, G Kaushal
Drug discoveries & therapeutics 12 (3), 142-153, 2018
52018
The system can't perform the operation now. Try again later.
Articles 1–20